Source: BioSpace

KeenEye Technologies: Keen Eye and Ultivue Announce Collaborative Agreement to Propel Multiplex and Spatial Analysis in Clinical Research

Keen Eye and Ultivue announce a collaborative agreement to promote multiplexed immunofluorescence (mIF) assays and scalable AI applications to unlock spatial analysis in clinical research.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Sylvain Berlemont's photo - Founder & CEO of KeenEye Technologies

Founder & CEO

Sylvain Berlemont

CEO Approval Rating

62/100

Read more